Therapy-related myelodysplastic syndromes

Hematol Oncol Clin North Am. 1992 Jun;6(3):707-22.

Abstract

This article summarizes the clinical aspects, cytogenetics, and initiating agents associated with therapy-related myelodysplastic syndromes. Details regarding associated chemotherapeutic agents and ionizing radiation are discussed and therapeutic considerations are presented.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Humans
  • Myelodysplastic Syndromes / chemically induced
  • Myelodysplastic Syndromes / etiology*
  • Myelodysplastic Syndromes / genetics
  • Radiotherapy / adverse effects*
  • Risk Factors

Substances

  • Antineoplastic Agents